Current Biology
Volume 9, Issue 11, 3 June 1999, Pages 601-604, S1
Journal home page for Current Biology

Brief Communications
Induction of NF-κB by the Akt/PKB kinase

https://doi.org/10.1016/S0960-9822(99)80265-6Get rights and content
Under an Elsevier user license
open archive

Abstract

The serine/threonine kinase Akt (also known as protein kinase B, PKB) is activated by numerous growth-factor and immune receptors through lipid products of phosphatidylinositol (PI) 3-kinase. Akt can couple to pathways that regulate glucose metabolism or cell survival [1]. Akt can also regulate several transcription factors, including E2F, CREB, and the Forkhead family member Daf-16 [2], [3], [4]. Here, we show that Akt can regulate signaling pathways that lead to induction of the NF-κB family of transcription factors in the Jurkat T-cell line. This induction occurs, at least in part, at the level of degradation of the NF-κB inhibitor IκB, and is specific for NF-κB, as other inducible transcription factors are not affected by Akt overexpression. Furthermore, the effect requires the kinase activity and pleckstrin homology (PH) domain of Akt. Also, Akt does not act alone to induce cytokine promoters and NF-κB reporters, because signals from other pathways are required to observe the effect. These studies uncover a previously unappreciated connection between Akt and NF-κB induction that could have implications for the control of T-cell growth and survival.

Cited by (0)

LP Kane and VS Shapiro, Department of Medicine, University of California, San Francisco, California 94143, USA.

D Stokoe, The Cancer Center, University of California, San Francisco, California 94143, USA.

A Weiss (corresponding author), Department of Medicine, The Howard Hughes Medical Institute, University of California, San Francisco, California 94143, USA. e-mail: [email protected].